Adenovirus mediated gene transfer to intestinal epithelial cells as a potential approach for oral delivery of peptides and proteins

Journal of Controlled Release

Volumn 46, Issue 1-2, 1997, Pages 75-87

  Walter, Elke ^a   Croyle, Maria A ^a   Davidson, Beverly L ^b   Roessler, Blake J ^c   Hilfinger, John M ^d   Amidon, Gordon L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d TSRL INC   (United States)

Author keywords

Adenovirus; Caco 2; Epithelial cell gene transfer; IBD; IL 1ra; Inflammatory bowel disease; Interleukin 1 receptor antagonist; Oral protein delivery

Indexed keywords

BETA GLUCOSIDASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PEPTIDES AND PROTEINS;

ADENOVIRUS; CELL STRAIN CACO 2; CONFERENCE PAPER; DRUG TRANSPORT; ENTERITIS; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; PRIORITY JOURNAL;

EID: 0031057469     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01584-2     Document Type: Conference Paper

References (53)

1. M.D. Taylor and G.L. Amidon, Peptide-based drug design, American Chemical Society, Washington, 1995.
2. J.A. Wolff, Gene Therapeutics Methods and applications of direct gene transfer, Birkhaeuser, Boston, 1994.
3. K.R. Youngman, P.L. Simon, G.A. West, F. Cominelli, D. Rachmilewitz, J.S. Klein and C. Fiocchi, Localization of intestinal interleukin-1 activity and protein and gene expression to lamina propria cells, Gastroenterology 104 (1993) 749-758.
4. J.C. Mansfield, H. Holden, J.K. Tarlow, F.S. Di-Giovine, T.L. McDowell, A.G. Wilson, C.D. Holdsworth and G.W. Duff, Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist, Gastroenterology 106 (1994) 637-642.
5. F. Cominelle, C.C. Nast, B.D. Clark, R. Schindler, R. Llerena, V.E. Eysselein, R.C. Thompson and C.A. Dinarello, Interleukin 1 (IL-1) gene expression, synthesis, and effect on specific IL-1 receptor blockade in rabbit immune complex colitis, J. Clin. Invest. 86 (1990) 972-980.
6. B.N. Fields and D.M. Knipe, Fundamental Virology, Raven Press, New York, 1994.
7. B.A. Rubin and L.B. Rorke, Adenovirus Vaccines, in: S.A. Plotkin and E.A. Mortimer (Eds), Vaccines, 2nd. ed., W.B. Saunders, Philadelphia, 1994, pp. 475-502.
8. A.Z. Kapikian, Viral Infections of the Gastrointestinal Tract, Marcel Dekker, New York, 1994.
9. R.J. Guzman, P. Lemarchand, R.G. Crystal, S.E. Epstein and T. Finkel, Efficient and selective adenovirus-mediated gene transfer into vascular neotima, Circulation 88 (1993) 2838-2848.
10. A. Kass-Eisler, E. Falck-Pedersen, M. Alvira, J. Rivera, P.M. Buttrick, B.A. Wittenberg, L. Cipriani and L.A. Leinwand, Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo, Proc. Natl. Acad. Sci. USA 90 (1993) 11498-11502.
11. B.J. Roessler, J.W. Hartman, D.V. Vallance, J.M. Latta, S.L. Janich and B.L. Davidson, Inhibition of interleukin-1-induced effects in synoviocytes transduced with human IL-1 receptor antagonist cDNA using an adenoviral vector, Hum. Gene Ther. 6 (1995) 307-316.
12. J.M. Friedman, L.E. Babiss, D.F. Clayton and J.E. Darnell, Cellular promotors incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression, Mol. Cell. Biol. 6 (1986) 3791-3797.
13. L.E. Babiss, J.M. Friedman and J.E. Darnell, Cellular promotors incorporated into adenovirus genome: effects of viral regulatory elements on the transcription rates and cell specificity of albumin and beta-globulin promotors, Mol. Cell. Biol. 6 (1986) 3798-3860.
14. S.K. Mittal, M.R. McDermott, D.C. Johnson, L. Prevec and F.L. Graham, Virus Res 28 (1993) 67-90.
15. B.J. Roessler, E.D. Allen, J.M. Wilson, J.W. Hartman and B.L. Davidson, Adenoviral-mediated gene transfer in rabbit synovium in vivo, J. Clin. Invest. 92 (1993) 1085-1092.
16. P. Artursson, Cell cultures as models for drug absorption across the intestinal mucosa, Crit. Rev. Ther. Drug Carrier Syst. 8 (1991) 305-330.
17. I.J. Hidalgo, T.J. Raub and R.T. Borchardt, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology 96 (1989) 736-749.
18. J.N. Cogburn, M.G. Donovan and C.S. Schasteen, A model of human small intestinal absorptive cells 1. Transport barrier, Pharm. Res 8 (1991) 211-216.
19. A.R. Hilgers, R.A. Conradi and P.S. Burton, Caco-2 cell monolayer as a model for drug transport across the intestinal mucosa, Pharm. Res 9 (1990) 902-910.
20. P.S. Burton, R.A. Conradi, A.R. Hilgers and N.F.H. Ho, Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells, Biochem. Biophys. Res Commun. 190 (1993) 760-766.
21. M.G. Traber, H.J. Kayden and M.J. Rindler, Polarized secretion of newly synthesized lipoproteins by the Caco-2 human intestinal cell line, J. Lipid. Res 28 (1987) 1350-1363.
22. M.J. Rindler and M.G. Traber, A specific sorting signal is not required for the polarized secretion of newly synthesized proteins from cultured intestinal epithelial cells, J. Cell Biol. 107 (1988) 471-479.
23. F.L. Graham and A.J. van Eb, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology 52 (1973) 456-467.
24. B. Precious and W.C. Russell, Growth, purification and titration of adenovi ruses, in: B.W.J. Mahy (Ed.), Virology: A Practical Approach, Vol. 9, IRL Press, Washington, 1986, pp. 193-205.
25. J.H. Miller, A Short Course in Bacterial Genetics, Vol. 3, CSHL Press, New York, 1992, pp. 78-79.
26. G.R. MacGregor, A.E. Mogg, J.F. Burke and C.T. Caskey, Histochemical staining of clonal mammalian cell lines expressing E. coli β galactosidase indicates heterogeneous expression of the bacterial gene, Somatic Cell Mol. Genet. 13 (1987) 253-265.
27. L.J. Sturzenbecker, M. Nibert, D. Furlong and B.N. Fields, lntracellular digestion of reovirus particles require a low pH and is an essential step in the viral infectious cycle, J.Virol. 61 (1987) 2351-2361.
28. G. Wilson, I.F. Hassan, C.J. Dix, I. Williamson and M. Mackay, Transport and permeability properties of human Caco-2 cells An in vitro model of the intestinal epithelial cell barrier, J. Control. Release 11 (1990) 25-40.
29. A. Allen, A. Garner, D. Hutton and S. McQueen, Thickness of the adherent mucus gel layer in the stomach and duodenum: Comparison with surface pH gradients in the rat and frog, J. Physiol. 341 (1983) 66P-67P
30. J.F. Forstner and G.D. Forstner, Gastrointestinal mucus, in: L.R. Johnson (Ed.), Physiology of the Gastrointestinal Tract, Raven Press, New York, 1994, pp. 1255-1283.
31. S. Kerss, A. Allen and A. Garner, A simple method for measuring the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents, Clin. Sci. 63 (1982) 187-195.
32. D.M. Bass, D. Bodkin, R. Dambrauskas, J.S. Trier, B.N. Fields and J.L. Wolf, Intraluminal proteolytic activation plays an important role in replication of type I reovirus in the intestines of neonatal mice, J. Virol. 64 (1990) 1830-1833.
33. S.M. Clark, J.R. Roth, M.L. Clark, B.B. Barnett and R.S. Spendlove, Trypsin enhancement of rotavirus infectivity: Mechanism of enhancement, J. Virol. 39 (1981) 816-822.
34. M.K. Estes, D.Y. Graham and B.B. Mason, Proteolytic enhancement of rotavirus infectivity: molecular mechanisms, J. Virol. 39 (1981) 879-888.
35. R.D. Specian and M.G. Oliver, Functional biology of intestinal goblet cells, Am. J. Physiol. 260 (1991) C183-C193.
36. P.H. Vachon and J.F. Beaulieu, Transient mosaic pattern of morphological and functional differentiation in the Caco-2 cell line, Gastroenterology 103 (1992) 414-423.
37. BBe cells, J. Cell. Sci. 105 (1993) 461-472.
38. M. Pinto, S. Robine-Leon, M.D. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. Lacroix, P. Simon-Assmann, K. Haffen, J. Fogh and A. Zweibaum, Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture, Biol. Cell 47 (1983) 323-330.
39. B. Gumbiner, Structure, biochemistry, and assembly of epithelial tight junctions, Am. J. Physiol. 253 (1987) C749-C758.
40. L.R. Johnson, Physiology of the Gastrointestinal Tract, Raven Press, New York, 1994.
41. B.R. Grubb, R.J. Pickles, H. Ye, J.R. Yankashas, R.N. Vick, J.F. Engelhardt, J.M. Wilson, L.G. Johnson and R.C. Boucher, Ineffective gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans, Nature 371 (1994) 802-806.
42. D. Rachmilewitz, R. Eliakim, P. Simon and F. Karmeli, Cytokines and platelet-activating factor in human inflamed colonic mucosa, Agents Actions Spec. No (1992) C32-C36.
43. R.C. Thompson, D.J. Dripps and S.P. Eisenberg, Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease, Int. J. Immunopharmacol. 14 (1992) 475-480.
44. M. Ligumsky, P.L. Simon, F. Karmeli and D. Rachmilewitz, Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease, Gut 31 (1990) 686-689.
45. V. Casini-Raggi, L. Kam, Y.J.T. Chong, C. Fiocchi, T.T. Pizarro and F. Cominelli, Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic inflammation, J. Immunol. 154 (1995) 2434-2440.
46. T. Nishiyama, K. Mitsuyama, A. Toyonga, E. Sasaki and K. Tanikawa, Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease, Digestion 55 (1994) 368-373.
47. M.E. Sher, A.J. D'Angelo, T.A. Stein, B. Bailey and G. Burns, Cytokines in Crohn's colitis, Am. J. Surg. 169 (1995) 133-136.
48. J. Brynskov, N. Tvede, C.B. Andersen and M. Villen, Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease, Gut 33 (1992) 55-58.
49. S. Yei, N. Mittereder, S. Wert, J.A. Whitsett, R.W. Wilmott and B.C. Trapnell, In vivo evaluation of the safety of adenovirus-mediated transfer to the human cystic fibrosis transmembrane conductance regulator cDNA to the lung, Hum. Gene Ther. 5 (1994) 731-744.
50. R.H. Simon, J.F. Engelhardt, Y. Yang, M. Zepeda, S.W. Pendleton, M. Grossman and J.M. Wilson, Adenovirus-mediated gene transfer to the CFTR gene to the lung of nonhuman primates toxicity studies, Hum. Gene Ther. 4 (1993) 821-836.
51. Y. Yang, F.A. Nunes, K. Berencsi, E. Gonczol, F.J. Engelhardt and J.M. Wilson, Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy, Proc. Natl. Acad. Sci. USA 91 (1994) 4407-4411.
52. C. Lau, H.E. Soriano, F.D. Ledley, M.J. Finegold, J.H. Wolfe, E.H. Birkenmeier and S.J. Henning, Retroviral gene transfer into the intestinal epithelium, Hum. Gene Ther. 6 (1995) 1145-1151.
53. J.W. Sandberg, C. Lau, M. Jacomino, M. Finegold and S.J. Henning, Improving access to intestinal stem cells as a step toward intestinal gene transfer, Hum. Gene Ther. 5 (1994) 323-329.